Treatment of prostate cancer by hypofractionated radiotherapy

Abstract

Technological advances in radiation therapy delivery havepermitted the use of high dose per fraction radiotherapy forearly stage prostate cancer. Level I evidence supportingthe safety and efficasy of hypofractionated radiotherapy isevolving. Moderate and extreme hypofractionation regimensshow promising cancer control but long term results ofnoninferiority studies of both modalities are required beforeuse in routine treatment as standard of care.Keywords: Prostate cancer, Curative radiotherapy,Moderate and extreme hypo fractionation